Effect of bifunctional IL2-GMCSF in promoting dendritic cell activation in vitro in simulated tumor-induced immune suppression.
- Author:
Qian WEN
1
;
Wenjing XIONG
;
Sudong LIU
;
Chaoying ZHOU
;
Li MA
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Cell Differentiation; Cell Line, Tumor; drug effects; Cell Proliferation; Chemokine CCL22; metabolism; Culture Media, Conditioned; chemistry; Dendritic Cells; cytology; drug effects; Gene Expression Regulation, Neoplastic; Granulocyte-Macrophage Colony-Stimulating Factor; pharmacology; Immune Tolerance; Interleukin-12; metabolism; Interleukin-2; pharmacology; Melanoma, Experimental; pathology; Mice; NF-kappa B; metabolism; Phagocytosis; STAT3 Transcription Factor; metabolism; Signal Transduction
- From: Journal of Southern Medical University 2015;35(9):1239-1244
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo test the effect of bifunctional molecule IL2-GMCSF in promoting the activation of dendritic cells (DCs) cultured in tumor conditioned medium.
METHODSWe prepared a tumor conditioned medium using mouse melanoma cell line B16F10 supplemented with IL2-GMCSF, GM-CSF, IL-2, or the combination of the latter two. After culturing mouse DC cell line DC2.4 in the conditioned medium for 24 h, the DCs were examined for phagocytosis, proliferation, maturation phenotype, cytokine secretion, and signal pathway activation.
RESULTSDC2.4 cells displayed characteristics of immature DCs. After cell culture in the conditioned medium, the cells showed enhanced phagocytosis but significantly suppressed cell proliferation activity. Culture in the conditioned medium also promoted DC cell maturation and secretion of macrophage-derived chemokine (MDC), but inhibited IL-12 secretion. Supplementation of the conditioned medium with IL2-GMCSF promoted phagocytosis, proliferation, maturation, and cytokine (including both IL-12 and MDC) secretion of DC2.4 cells. Compared with GM-CSF, IL2-GMCSF induced a higher level of NF-κB signal pathway activation but suppressed STAT3 activation.
CONCLUSIONCompared with GM-CSF, IL2-GMCSF can better promote DC activation in the context of tumor-induced immune suppression, and thus shows potentials in anti-tumor therapy.